In recent years, cancer immunotherapy based on immune checkpoint inhibitors (ICIs) has achieved considerable success in the clinic. However, ICIs are significantly limited by the fact that only one third of patients with most types of cancer respond to these agents. The induction of cell death mecha...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!